Actionable news
0
All posts from Actionable news
Actionable news in RXII: RXI PHARMACEUTICALS CORPORATION,

RXi Pharmaceuticals Corporation (RXII)

Research Development1,734 1,361 2,107 1,562
Total Operating Expenses - - - -
Operating Income or Loss (2,504) (2,165) (2,946) (2,306)
Earnings Before Interest And...

More